Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
cisplatin (platinol) (1 trial)
gemcitabine (gemzar) (1 trial)
Carcinoma (Phase 3)
Cholangiocarcinoma (Phase 3)
Gallbladder Neoplasms (Phase 3)
Urinary Bladder Neoplasms (Phase 3)
Trials (1 total)
Trial APIs (2 total)